Pretreatment waveform for irreversible electroporation

The electroporation ablation system addresses the issue of SMS in IRE by using a preconditioning pulse sequence to induce electrolysis and tetany, followed by a closed-loop system for precise tissue ablation, achieving effective and targeted tissue damage without harming non-targeted cells.

JP2024169703AActive Publication Date: 2024-12-05BOSTON SCIENTIFIC SCIMED INC
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2024167207
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-09-30
Filing Date
2024-09-26
Publication Date
2024-12-05
Estimated Expiration
2041-09-28

AI Technical Summary

Technical Problem

Existing ablation techniques like RF and cryoablation indiscriminately damage healthy tissue, while irreversible electroporation (IRE) can cause skeletal muscle stimulation (SMS) and require refinement to optimize energy delivery.

Method used

An electroporation ablation system with a catheter and generator that includes a preconditioning pulse sequence to induce electrolysis and tetany, followed by an electroporation pulse sequence to deliver targeted tissue ablation, using a closed-loop system with an accelerometer to monitor skeletal muscle stimulation.

Benefits of technology

The system effectively ablates target tissue without damaging non-targeted cells, reducing SMS and optimizing energy delivery for precise lesions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024169703000001_ABST
    Figure 2024169703000001_ABST
Patent Text Reader

Abstract

To provide an electroporation ablation system for treating targeted tissue in a patient.SOLUTION: The electroporation ablation system includes an ablation catheter and an electroporation generator. The ablation catheter includes a handle, a shaft having a distal end, and catheter electrodes situated at the distal end of the shaft and spatially arranged to generate electric fields in the targeted tissue in response to electrical pulses. The electroporation generator is operatively coupled to the catheter electrodes and configured to deliver the electrical pulses in an irreversible electroporation pulse sequence, which includes a preconditioning pulse sequence and an electroporation pulse sequence, to one or more catheter electrodes. The preconditioning pulse sequence includes multiple preconditioning electrical pulses configured to cause electrolysis near the targeted tissue and tetanizing skeletal muscle stimulation in the patient.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] FIELD OF THE DISCLOSURE The present disclosure relates to medical devices, systems, and methods for ablating tissue in a patient, and more particularly, the present disclosure relates to medical devices, systems, and methods for ablation of tissue by electroporation. [Background technology]

[0002] Ablation procedures are used to treat many different conditions in patients. Ablation can be used to treat cardiac arrhythmias, benign tumors, cancerous tumors, and to control bleeding during surgery. Typically, ablation is accomplished by thermal ablation techniques, including radiofrequency (RF) ablation and cryoablation. In RF ablation, a probe is inserted into the patient and radiofrequency waves are transmitted through the probe to the surrounding tissue. The radiofrequency waves generate heat, which destroys the surrounding tissue and cauterizes blood vessels. In cryoablation, a hollow needle or cryoprobe is inserted into the patient and a cold, thermally conductive fluid is circulated through the probe to freeze and kill the surrounding tissue. RF ablation and cryoablation techniques indiscriminately kill tissue by cellular necrosis, which can damage or kill otherwise healthy tissue, such as tissue in the esophagus, phrenic nerve cells, and tissue in the coronary arteries.

[0003] Another ablation technique uses electroporation. In electroporation or electropermeabilization, an electric field is applied to cells to increase the permeability of the cell membrane. Electroporation can be reversible or irreversible, depending on the strength of the electric field. If electroporation is reversible, the increased permeability of the cell membrane can be used to introduce chemicals, drugs, and / or deoxyribonucleic acid (DNA) into the cells prior to cell healing and recovery. If electroporation is irreversible, the affected cells die by apoptosis.

[0004] Irreversible electroporation (IRE) can be used as a non-thermal ablation technique. In IRE, a train of short high-voltage pulses is used to generate an electric field strong enough to kill cells by apoptosis. In ablation of cardiac tissue, IRE can be a safe and effective alternative to the indiscriminate killing of thermal ablation techniques such as RF ablation and cryoablation. IRE can be used to kill target tissues such as myocardial tissues by using an electric field strength and duration that kills the target tissue but does not permanently damage other cells or tissues such as non-target myocardial tissues, red blood cells, vascular smooth muscle tissues, endothelial tissues, and nerve cells.

[0005] In some IRE procedures, the electroporation electrical pulse causes the undesirable side effect of skeletal muscle stimulation (SMS) and engagement. One way to reduce SMS is to refine the IRE electrical pulse and optimize the pulse to avoid SMS. In many cases, this results in having a smaller ablation field and creating a smaller lesion. A method is needed to deliver effective IRE energy while avoiding SMS. Summary of the Invention

[0006] In Example 1, an electroporation ablation system for treating a target tissue of a patient. The electroporation ablation system includes an ablation catheter and an electroporation generator. The ablation catheter includes a handle, a shaft having a distal end, and a catheter electrode located at the distal end of the shaft and spatially arranged to generate an electric field in the target tissue in response to an electric pulse. The electroporation generator is operatively coupled to the catheter electrode and configured to deliver electric pulses to the one or more catheter electrodes in an irreversible electroporation pulse sequence including a preconditioning pulse sequence and an electroporation pulse sequence. The preconditioning pulse sequence includes a plurality of preconditioning electric pulses configured to cause electrolysis near the target tissue and tetanic skeletal muscle stimulation in the patient.

[0007] In Example 2, the electroporation ablation system of Example 1 includes a surface patch electrode attached to a patient and configured to generate an electric field within the patient in response to an electrical pulse.

[0008] In Example 3, the electroporation ablation system of Example 2, wherein the preconditioning pulse sequence includes multiple monopolar electrical pulses sourced from a surface patch electrode and sunk by one or more catheter electrodes.

[0009] In Example 4, the electroporation ablation system of Example 2, wherein the preconditioning pulse sequence includes a plurality of monopolar electrical pulses sourced from one or more catheter electrodes and sunk by a surface patch electrode.

[0010] In Example 5, the electroporation ablation system of any one of Examples 1 to 4, wherein the preconditioning pulse sequence includes a plurality of bipolar electrical pulses sourced from at least one of the one or more catheter electrodes and sunk by at least another one of the one or more catheter electrodes.

[0011] In Example 6, the electroporation ablation system of any one of Examples 1-5, wherein the preconditioning pulse sequence includes a plurality of preconditioning pulses delivered at a selected frequency.

[0012] In Example 7, the electroporation ablation system of any one of Examples 1-6, wherein the preconditioning pulse sequence includes a plurality of preconditioning pulses that increase in voltage from a lower voltage to a higher voltage over time.

[0013] In Example 8, the perforation ablation system of any one of Examples 1 to 7, wherein the preconditioning pulse sequence includes a plurality of preconditioning pulses including an exponentially decaying trailing waveform that causes electrolysis near the target tissue.

[0014] In Example 9, the electroporation ablation system of any one of Examples 1-8, wherein the preconditioning pulse sequence includes a plurality of preconditioning pulses that are monophasic.

[0015] In Example 10, the electroporation ablation system of any one of Examples 1-9, wherein the irreversible electroporation pulse sequence including the preconditioning pulse sequence and the electroporation pulse sequence is delivered to the patient within one or more of the patient's cardiac refractory time, less than 330 milliseconds, and a time window of 100 to 250 milliseconds.

[0016] In Example 11, the electroporation ablation system of any one of Examples 1-10, wherein the electroporation pulse sequence is delivered within a preconditioning pulse sequence.

[0017] Example 12 is the electroporation ablation system of any one of Examples 1-11, wherein the electroporation pulse sequence includes a plurality of bipolar electrical pulses delivered to one or more catheter electrode pairs of the catheter electrodes.

[0018] In Example 13, the electroporation ablation system of any one of Examples 1 to 12 includes an accelerometer configured to monitor skeletal muscle stimulation of the patient, and the electroporation ablation system is a closed loop system in which the electroporation generator is configured to deliver a preconditioning pulse sequence, detect tetany in the patient, and thereafter deliver an electroporation pulse sequence, and local impedance is measured to calculate pre-ablation and post-ablation values ​​and assess lesion efficacy.

[0019] In Example 14, an electroporation ablation system for treating a target tissue of a patient. The electroporation ablation system includes an ablation catheter and an electroporation generator. The ablation catheter includes a handle, a shaft having a distal end, and a catheter electrode located at the distal end of the shaft and spatially arranged to generate an electric field in the target tissue in response to an electric pulse. The electroporation generator is operably coupled to a plurality of electrodes including one or more of a surface patch electrode and one or more catheter electrodes, and is configured to deliver electric pulses to the plurality of electrodes in an irreversible electroporation pulse sequence including a preconditioning pulse sequence and an electroporation pulse sequence, and delivers the electroporation pulse sequence during the preconditioning pulse sequence.

[0020] In Example 15, the electroporation ablation system of Example 14, wherein the preconditioning pulse sequence includes a plurality of electrical pulses configured to induce electrolysis near the target tissue and tetanic skeletal muscle stimulation in the patient.

[0021] In Example 16, an electroporation ablation system for treating a target tissue of a patient. The electroporation ablation system includes an ablation catheter and an electroporation generator. The ablation catheter includes a handle, a shaft having a distal end, and a catheter electrode located at the distal end of the shaft and spatially arranged to generate an electric field in the target tissue in response to an electric pulse. The electroporation generator is operably coupled to the catheter electrode and configured to deliver electric pulses to one or more catheter electrodes in an irreversible electroporation pulse sequence including a preconditioning pulse sequence and an electroporation pulse sequence, and the preconditioning pulse sequence includes a plurality of preconditioning electric pulses configured to cause electrolysis near the target tissue and tetanic skeletal muscle stimulation in the patient.

[0022] In Example 17, the electroporation ablation system of Example 16 includes a surface patch electrode attached to a patient and configured to generate an electric field within the patient in response to an electrical pulse.

[0023] In Example 18, the electroporation ablation system of Example 16, wherein the preconditioning pulse sequence includes a plurality of monopolar electrical pulses sourced from a surface patch electrode and sunk by one or more catheter electrodes.

[0024] In Example 19, the electroporation ablation system of Example 16, wherein the preconditioning pulse sequence includes a plurality of monopolar electrical pulses sourced from one or more catheter electrodes and sunk by a surface patch electrode.

[0025] In Example 20, the electroporation ablation system of Example 16, wherein the preconditioning pulse sequence includes a plurality of bipolar electrical pulses sourced from at least one of the one or more catheter electrodes and sunk by at least another one of the one or more catheter electrodes.

[0026] In Example 21, the electroporation ablation system of Example 16, wherein the preconditioning pulse sequence includes a plurality of preconditioning pulses delivered at a selected frequency.

[0027] In Example 22, the electroporation ablation system of Example 16, wherein the preconditioning pulse sequence includes multiple preconditioning pulses that increase in voltage from a lower voltage to a higher voltage over time.

[0028] In Example 23, the perforation ablation system of Example 16, wherein the preconditioning pulse sequence includes a plurality of preconditioning pulses including an exponentially decaying trailing waveform that causes electrolysis near the target tissue.

[0029] In Example 24, the electroporation ablation system of Example 16, wherein the preconditioning pulse sequence includes multiple preconditioning pulses that are monophasic.

[0030] In Example 25, the electroporation ablation system of Example 16, wherein the irreversible electroporation pulse sequence including the preconditioning pulse sequence and the electroporation pulse sequence is delivered to the patient within one or more of the patient's cardiac refractory time, less than 330 milliseconds, and a time window of 100 to 250 milliseconds.

[0031] In Example 26, the electroporation ablation system of Example 16, wherein the electroporation pulse sequence is delivered within a preconditioning pulse sequence. Example 27 is the electroporation ablation system of example 16, wherein the electroporation pulse sequence includes a plurality of bipolar electrical pulses delivered to one or more catheter electrode pairs of the catheter electrodes.

[0032] In Example 28, the electroporation ablation system of Example 16 includes an accelerometer configured to monitor skeletal muscle stimulation of the patient, and the electroporation ablation system is a closed loop system in which the electroporation generator is configured to deliver a preconditioning pulse sequence, detect tetany in the patient, and thereafter deliver an electroporation pulse sequence, and measures local impedance to calculate pre-ablation and post-ablation values ​​and assess lesion efficacy.

[0033] In embodiment 29, an electroporation ablation system for treating a target tissue of a patient. The electroporation ablation system includes an ablation catheter and an electroporation generator. The ablation catheter includes a handle, a shaft having a distal end, and a catheter electrode located at the distal end of the shaft and spatially arranged to generate an electric field in the target tissue in response to an electric pulse. The electroporation generator is operably coupled to a plurality of electrodes including one or more of a surface patch electrode and one or more catheter electrodes, and is configured to deliver electric pulses to the plurality of electrodes in an irreversible electroporation pulse sequence including a preconditioning pulse sequence and an electroporation pulse sequence, and delivers the electroporation pulse sequence during the preconditioning pulse sequence.

[0034] In Example 30, the electroporation ablation system of Example 29, wherein the preconditioning pulse sequence includes a plurality of preconditioning electrical pulses configured to induce electrolysis near the target tissue and tetanic skeletal muscle stimulation in the patient.

[0035] Example 31 is the electroporation ablation system of example 29, wherein the electroporation pulse sequence includes a plurality of bipolar electrical pulses delivered to selected catheter electrode pairs. In Example 32, a method of ablating a target tissue in a patient by irreversible electroporation includes delivering an irreversible electroporation pulse sequence including delivering a preconditioning pulse sequence between a plurality of electrodes including one or more of a surface patch electrode and one or more catheter electrodes on a catheter to cause electrolysis near the target tissue and tetanic skeletal muscle stimulation in the patient, and delivering the electroporation pulse sequence to the plurality of electrodes to cause irreversible electroporation ablation of the target tissue.

[0036] In Example 33, the method of Example 32, wherein the step of delivering the preconditioning pulse sequence includes delivering a plurality of electrical pulses that increase in voltage from a lower voltage to a higher voltage over time, and one or more of the electrical pulses includes an exponentially decaying trailing waveform.

[0037] In Example 34, the method of Example 32, wherein the electroporation pulse sequence is delivered during the preconditioning pulse sequence. In Example 35, the method of Example 32 includes the steps of monitoring an accelerometer on the patient, delivering a preconditioning pulse sequence in a closed loop system to achieve tetany in the patient, detecting tetany in the patient by the accelerometer, and delivering an electroporation pulse sequence after tetany is achieved.

[0038] While multiple embodiments are disclosed, still other embodiments of the present disclosure will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the present disclosure. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive. [Brief description of the drawings]

[0039] [Figure 1] FIG. 1 illustrates an exemplary clinical setup for treating a patient using an electrophysiology system and for treating the patient's heart, in accordance with an embodiment of the presently disclosed subject matter. [Figure 2A] 1A-1C illustrate a distal end of a shaft included in a catheter and the interaction between an electrode pair, according to an embodiment of the presently disclosed subject matter. [Figure 2B] 1A-1C show diagrams illustrating axial electric fields generated by interaction between electrode pairs, according to embodiments of the presently disclosed subject matter. [Figure 2C] 1A-1C show diagrams illustrating circumferential electric fields generated by interaction between electrode pairs of a catheter, according to embodiments of the presently disclosed subject matter. [Diagram 3]FIG. 1 illustrates an IRE pulse sequence including a preconditioning pulse sequence and an electroporation pulse sequence, in accordance with an embodiment of the presently disclosed subject matter. [Figure 4] FIG. 1 is a flow chart diagram illustrating a method of ablating target tissue in a patient by irreversible electroporation, according to an embodiment of the presently disclosed subject matter.

[0040] While the present disclosure is susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the disclosure to the specific embodiments described. On the contrary, the disclosure is intended to cover all modifications, equivalents, and alternatives falling within the scope of the present disclosure as defined by the appended claims. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0041] The following detailed description is exemplary in nature and is in no way intended to limit the scope, applicability, or configuration of the present invention. Rather, the following description provides some practical illustrations for implementing exemplary embodiments of the present invention. Examples of configurations, materials, and / or dimensions are provided for selected elements. Those skilled in the art will recognize that many of the described examples have a variety of suitable alternatives.

[0042] FIG. 1 illustrates an exemplary clinical setup 10 for treating a patient 20 using an electrophysiology system 50 and for treating a heart 30 of the patient 20, in accordance with an embodiment of the subject matter of the present disclosure. The electrophysiology system 50 includes an electroporation system 60 and an electroanatomical mapping (EAM) system 70, which includes a localization field generator 80, a mapping and navigation controller 90, and a display 92. The clinical setup 10 also includes additional equipment, such as an imaging device 94 (represented by a C-arm), and various controller elements, such as a foot controller 96 configured to enable an operator to control various aspects of the electrophysiology system 50. As will be appreciated by those skilled in the art, the clinical setup 10 may have other components and arrangements of components not shown in FIG. 1.

[0043] Electroporation system 60 includes electroporation catheter 105, introducer sheath 110, surface patch electrode 115, and electroporation generator 130. In embodiments, electroporation system 60 also includes accelerometer 117, which may be a separate sensor or part of surface electrode patch 115. In addition, electroporation system 60 includes various connecting elements (e.g., cables, umbilicals, etc.) that serve to operatively connect the components of electroporation system 60 to each other and to the components of EAM system 70. The arrangement of the connecting elements is not critical to the present disclosure, and one of ordinary skill in the art will recognize that the various components described herein may be interconnected in a variety of ways.

[0044] In an embodiment, the electroporation system 60 is configured to deliver electric field energy to a target tissue within the patient's heart 30 to cause tissue apoptosis, thereby rendering the tissue unable to conduct electrical signals. The electroporation generator 130 is configured to control functional aspects of the electroporation system 60. In an embodiment, the electroporation generator 130 is operable as a pulse generator for generating and supplying pulse sequences to the electroporation catheter 105 and the surface patch electrodes 115, as described in more detail herein. In an embodiment, the electroporation generator 130 is operable to receive sensed signals from the accelerometer 117, and based on the received sensed signals, functions as a pulse generator for generating and supplying pulse sequences to the electroporation catheter 105 and the surface patch electrodes 115, as described in more detail herein.

[0045] In an embodiment, electroporation generator 130 includes one or more controllers, microprocessors, and / or computers that execute code from memory to control and / or implement functional aspects of electroporation catheter system 60. In an embodiment, the memory may be part of one or more controllers, microprocessors, and / or computers, and / or part of memory capacity accessible through a network, such as the World Wide Web.

[0046] In an embodiment, introducer sheath 110 is operable to provide a delivery conduit through which electroporation catheter 105 may be deployed to a particular target site within the patient's heart 30. However, it will be understood that while introducer sheath 110 is illustrated and described herein to provide context for the overall electrophysiology system 50, it is not necessary to the novel aspects of the various embodiments described herein.

[0047] The EAM system 70 is operable to track the positions of various functional components of the electroporation system 60 and generate high fidelity three-dimensional anatomical and electroanatomical maps of the subject's heart chambers. In an embodiment, the EAM system 70 may be a RHYTHMIA® HDx mapping system sold by Boston Scientific Corporation. Also, in an embodiment, the mapping and navigation controller 90 of the EAM system 70 includes one or more controllers, microprocessors, and / or computers that execute code from memory to control and / or implement the functional aspects of the EAM system 70, which in an embodiment may be part of one or more controllers, microprocessors, and / or computers, and / or memory capacity accessible via a network, such as the World Wide Web.

[0048] As will be appreciated by one of ordinary skill in the art, the diagram of electrophysiology system 50 shown in Figure 1 is intended to provide a general overview of the various components of system 50 and is not intended to imply in any way that the present disclosure is limited to any set of components or arrangement of components. For example, one of ordinary skill in the art will readily recognize that additional hardware components, e.g., breakout boxes, workstations, etc., may and likely will be included in electrophysiology system 50.

[0049] EAM system 70 defines a localization volume around heart 30 by generating a localization field via field generator 80, and one or more position sensors or sensing elements on the tracked device, such as electroporation catheter 105, track the position of the sensor, and thus the corresponding device, within the localization volume by generating outputs that can be processed by mapping and navigation controller 90. In the embodiment shown, device tracking is achieved using magnetic tracking techniques, such that field generator 80 is a magnetic field generator that generates a magnetic field that defines the localization volume, and the position sensors on the tracked device are magnetic field sensors.

[0050] In other embodiments, impedance tracking methods may be employed to track the location of various devices. In such embodiments, the localization fields are electric fields generated, for example, by external field generator arrangements such as surface electrodes, or by internal or intracardiac devices such as intracardiac catheters, or both. In these embodiments, the position sensing elements may constitute electrodes on the tracked devices that generate outputs that are received and processed by the mapping and navigation controller 90 to track the location of the various position sensing electrodes within the localization volume.

[0051] In embodiments, the EAM system 70 includes both magnetic and impedance tracking capabilities. In such embodiments, the accuracy of the impedance tracking can be improved in some cases by first creating a map of the electric field induced by the electric field generator in the subject's heart chamber using a probe that includes a magnetic position sensor, as is possible with the previously described RHYTHMIA HDx™ mapping system. One exemplary probe is the INTELLAMAP ORION® mapping catheter sold by Boston Scientific Corporation.

[0052] Regardless of the tracking method used, EAM system 70 utilizes the positional information of the various tracked devices, along with the cardiac electrical activity acquired, for example, by electroporation catheter 105 or another catheter or probe equipped with sensing electrodes, to create and display via display 92 a detailed three-dimensional geometrical anatomical map or representation of the heart chambers, as well as an electroanatomical map in which the subject's cardiac electrical activity is superimposed on the geometrical anatomical map. Additionally, EAM system 70 may create graphical representations of the various tracked devices within the geometrical anatomical map and / or the electroanatomical map.

[0053] Although EAM system 70 is shown in combination with electroporation system 60 to provide a comprehensive view of exemplary clinical facility 10, EAM system 70 is not essential to the operation and functionality of electroporation system 60. That is, in embodiments, electroporation system 60 can be used independently of EAM system 70 or any equivalent electroanatomical mapping system.

[0054] In the embodiment shown, electroporation catheter 105 includes a handle 105a, a shaft 105b, and an electroporation electrode configuration 150, which is described further below. Handle 105a is configured to be manipulated by a user to position electroporation electrode configuration 150 at a desired anatomical location. Shaft 105b has a distal end 105c and generally defines a longitudinal axis of electroporation catheter 105. As shown, electroporation electrode configuration 150 is located at or proximal to distal end 105c of shaft 105b. In an embodiment, electroporation electrode configuration 150 is electrically coupled to electroporation generator 130 to receive an electrical pulse sequence or train, thereby selectively generating an electric field for ablating target tissue by irreversible electroporation.

[0055] In an embodiment, the surface patch electrode 115 comprises a conductive electrode that can be attached to the body of the patient 20, such as the patient's chest. The surface patch electrode 115, including the conductive electrode, is electrically coupled to the electroporation generator 130 to act as a return path or sink of electrical energy in the system and to receive an electrical pulse sequence or train from the electroporation generator 130, thereby acting as a source of electrical energy to selectively generate an electric field for ablating the target tissue by irreversible electroporation. In an embodiment, the surface patch electrode 115 acts as a return or sink for electrical energy received by the electroporation catheter 105 and the electroporation electrode configuration 150. In an embodiment, the surface patch electrode 115 acts as a source of electrical energy and the electroporation catheter 105, including the electroporation electrode configuration 150, acts as a return or sink for the sourced electrical energy.

[0056] The electroporation system 60 is operable to generate IRE pulse sequences, including a preconditioning pulse sequence and an electroporation pulse sequence. The IRE pulse sequence is configured to ablate the target tissue. In an embodiment, the preconditioning pulse sequence is a series of electrical pulses of increasing magnitude to induce tetany in skeletal muscle tissue and to provide electrolysis near the target tissue. In an embodiment, the electroporation pulse sequence is a series of electroporation pulses configured to cause irreversible damage to the target tissue.

[0057] In an embodiment, electroporation system 60 includes an accelerometer 117 that may be attached to the body of patient 20, such as the patient's chest, and electrically coupled to electroporation generator 130. Accelerometer 117 is configured to detect tetany by sensing contractions of the patient's skeletal musculature. Signals from accelerometer 117 are received by electroporation generator 130, which processes the signals to determine whether the patient's skeletal musculature is contracting and whether tetany has been achieved. In an embodiment, electroporation generator 130 is configured to provide an electroporation pulse sequence only after tetany has been achieved in the patient.

[0058] In an embodiment, electroporation system 60 operates as a closed system with surface accelerometer 117 monitoring chest vibrations and electroporation generator 130 modulating pulses until tetany is achieved, after which electroporation generator 130 delivers the electroporation pulse. Also, in an embodiment, the local impedance of the target tissue and tissue surrounding the target tissue can be measured during this time to calculate pre- and post-ablation values ​​to assess lesion efficacy.

[0059] 2A-2C illustrate features of an electroporation catheter 105 including an electroporation electrode configuration 150 according to an exemplary embodiment. In the embodiment shown in FIG. 2A, the electroporation electrode configuration 150 includes a plurality of electrodes 201a, 201b, 201c, 201d, 201e, and 201f arranged in a three-dimensional electrode array, with each of the electrodes 201a, 201b, 201c, 201d, 201e, and 201f spaced apart from one another axially (i.e., in the direction of the longitudinal axis LA), circumferentially around the longitudinal axis LA, and / or radially relative to the longitudinal axis LA. In some embodiments, electrodes 201a, 201b, 201c, 201d, 201e, and 201f are each individually selectively addressable via electroporation generator 130 (FIG. 1) to define a plurality of anode-cathode electrode pairs, each of which can receive an electrical pulse sequence from electroporation generator 130 to generate an electric field that can selectively target tissue by electroporation, including ablating target tissue by IRE. FIG. 2A shows a schematic representation of the interactions (e.g., current flow forming an electric field) between electrodes 201 (e.g., 201a, 201b, 201c, 201d, 201e, and 201f) included in electroporation catheter 105. In this figure, the interactions are shown as paired arrows (e.g., ad, be, and df) showing current flow between electrodes 201. Also, electrode pairs (eg, 201a and 201d, 201b and 201e, and 201d and 201f) are shown labeled with their respective current flows (eg, ad, be, and df).

[0060] 2B is a diagram illustrating an electric field 210 generated by the interaction between an electrode pair within the electroporation catheter 105. In this figure, an axially oriented electric field 210 is shown positioned at the ostium 221 between the left atrium 223 and the left inferior pulmonary vein 225. In an embodiment, the axially oriented electric field 210 is generated by delivering electrical pulses to axially spaced anodes and cathodes.

[0061] 2C also illustrates an electric field 210 generated by the interaction between a pair of electrodes within the electroporation catheter 105. Here, however, the electric field 210 is circumferentially oriented. In an embodiment, the circumferentially oriented electric field 210 is generated by delivering electrical pulses to a circumferentially spaced anode ("A") and cathode ("C").

[0062] 2A-2C illustrate that multiple electric fields 210 may be generated simultaneously and / or sequentially in axial and circumferential orientations. For example, in embodiments, axially and circumferentially oriented electric fields 210 may be generated non-simultaneously in a predefined sequence by selectively controlling the timing of the delivery of electrical pulses to each electrode 201. In addition, it is understood that intermittently generated electric fields 210 caused by staggered interactions between sets of electrode pairs, as well as electric field orientations other than axial and circumferential, are not beyond the scope of the present disclosure.

[0063] As can be seen in FIG. 2A, the electroporation electrode configuration 150 may include a plurality of individually addressable electrodes 201 (e.g., anodes or cathodes) arranged to selectively define a plurality of electrode pairs (e.g., anode-cathode pairs). Each anode-cathode pair may be configured to generate an electric field when a pulse sequence is delivered thereto. The plurality of anode-cathode pairs may include at least two of a first anode-cathode pair, a second anode-cathode pair, and a third anode-cathode pair. The first anode-cathode pair may be arranged to generate a first electric field oriented generally circumferentially relative to the longitudinal axis when a first pulse sequence is delivered thereto. The second anode-cathode pair may be arranged to generate a second electric field oriented generally in the same direction as the longitudinal axis when a second pulse sequence is delivered thereto. A third anode-cathode pair may be arranged to generate a third electric field oriented generally transverse to the longitudinal axis when a third pulse sequence is delivered thereto. In embodiments, any combination of the first, second and third pulse sequences may be delivered simultaneously or intermittently and may take a variety of forms.

[0064] In an embodiment, the electroporation electrode structure 150 may be configured to structurally arrange the electrodes 201a, 201b, 201c, 201d, 201e, and 201f in a distally located first region and a more proximally located second region. Thus, electrode pairs may be formed across the various electrodes 201 in the electroporation electrode structure 150 between the first and second regions. For example, electrodes 201d and 201f may be configured to form an electrode pair. Similarly, electrodes 201a and 201d, or electrodes 201b and 201e, or combinations thereof, may be selected to form respective electrode pairs. Thus, an electrode pair may include axially spaced electrodes, laterally spaced electrodes, or circumferentially spaced electrodes. Additionally, in an embodiment, a given electrode (e.g., 201d) may function as a common electrode in at least two electrode pairs to generate the electric field 210.

[0065] FIG. 2B shows a diagram of an exemplary electric field 210 that may be generated by the electroporation electrode configuration 150. The electroporation electrode configuration 150 may be configured to generate a multi-directional electric field 210 when at least one pulse sequence is delivered thereto. The multi-directional electric field 210 may include at least two of a generally axial, circumferential, and transverse direction relative to the longitudinal axis. As used herein, transverse may mean any non-parallel angle relative to the longitudinal axis. As described elsewhere herein, the electroporation electrode configuration 150 may be configured to operably couple to an electroporation generator configured to generate at least one pulse sequence. The electroporation electrode configuration 150 may be configured to receive at least one pulse sequence from the electroporation generator. Thus, the electroporation electrode configuration 150 and the electroporation generator may be in operative communication with each other. In the present disclosure, such communication may be used to generate at least a substantially gap-free electric field 210.

[0066] Undesirable gaps in the electric field 210 generated by the electroporation electrode configuration 150 may be limited or at least substantially eliminated. Such gaps may potentially result in lesion gaps and thus require, for example, multiple repositioning of the catheter. By overlapping the electric fields 210, the number of such gaps may be at least substantially limited. In an embodiment, at least some of the electric fields 210 generated in the first pulse sequence set may at least partially overlap each other. For example, adjacent electric fields 210 (e.g., axially, laterally, and / or circumferentially) in the composite electric field 211 may cross each other such that no gaps are limited in the composite electric field 211. The overlap may occur at or near the periphery of adjacent electric fields 210, or may occur over a majority or majority of one or more adjacent electric fields 210. In this disclosure, adjacent means electrodes 201 that are next to each other or that are otherwise close to each other. The electroporation generator may be configured to generate a pulse sequence for use in generating the overlapping electric fields.

[0067] The configuration of the electroporation electrode configuration 150 in various embodiments can take any form suitable for a three-dimensional electrode structure, whether now known or later developed. In an exemplary embodiment, the electroporation electrode configuration 150 can be in the form of a spline basket catheter, with each electrode 201a, 201b, 201c, 201d, 201e, and 201f arranged on a plurality of splines in any manner known in the art. In an embodiment, the electroporation electrode configuration 150 can be formed on an expandable balloon, for example, the electrodes are formed on flexible circuit branches or individual traces arranged on the balloon surface. In other embodiments, the electroporation electrode configuration 150 can be in the form of an expandable mesh. In short, the particular structure used to form the electroporation electrode configuration 150 is not essential to the embodiments of the present disclosure.

[0068] 3 illustrates an ablation energy application sequence 300, also referred to herein as an IRE pulse sequence 300, including a preconditioning pulse sequence 302 and an electroporation pulse sequence 304, according to an exemplary embodiment. The preconditioning pulse sequence 302 is a series of pulses 306 that increase in magnitude from lower to higher voltages. The electroporation pulse sequence 304 is a series of high energy electroporation pulses 308 with large positive and / or negative voltage values.

[0069] The electroporation system 60 is configured to deliver a preconditioning pulse sequence 302 that delivers a series of pulses 306 or a sequence of pulses 306 to achieve tetany and to generate electrolysis. Although only three pulses 306 of the preconditioning pulse sequence 302 are pointed to in FIG. 3 for clarity of illustration, in an embodiment, the sequence of pulses 306 includes all pulses in the preconditioning pulse sequence 302. The electroporation system 60 is further configured to deliver an electroporation pulse sequence 304, i.e., electroporation ablation energy, in a series of electroporation pulses 308 to ablate the target tissue. In an embodiment, all pulses in the IRE pulse sequence 300 are delivered within the refractory period of the heart, such as within 250-330 milliseconds.

[0070] The sequence of pulses 306 is a series of monophasic pulses that increase in magnitude from lower to higher voltages over time. The voltage ramping causes a relatively slow recruitment of skeletal muscle, ultimately resulting in a tetanic skeletal muscle contraction prior to the higher voltage electroporation pulse 308 in the electroporation pulse sequence 304. Each of the pulses 306, or at least some of the pulses 306, also have features that promote electrolysis, such as including a monophasic exponentially decaying waveform 310 (or drooping waveform) behind the pulse 306. Although only three of the exponentially decaying waveforms 310 in the preconditioning pulse sequence 302 are pointed out in FIG. 3 for clarity of illustration, in an embodiment, all pulses in the preconditioning pulse sequence 302 include an exponentially decaying waveform 310. In an embodiment, the pulses 306 may not be completely monophasic, but may include at least some asymmetric phases that are charge balanced with both positive and negative components. In some embodiments, the duration of the pulse 306 is between 1 millisecond (ms) and 60 ms, and in some embodiments, the slope / droop / exponential decay of the waveform is within 20 to 80% of the leading edge.

[0071] The pulses 306 may have a number of different characteristics. In embodiments, the pulses 306 in the preconditioning pulse sequence 302 are provided at a selected frequency, such as 1 kilohertz. In some embodiments, the frequency is in the range of 200-1000 Hz. In embodiments, the pulses 306 are ramped from 0 volts to a voltage of 5-100 volts, and in some embodiments, the amplitude reaches 100-1000 volts. Also, in embodiments, the ramp rate can be in increments of 1%-30% of the preceding pulse. In some embodiments, the preconditioning pulse sequence 302 is applied with a sequence duration of 100-250 milliseconds.

[0072] The preconditioning pulse sequence 302 preconditions the body for electroporation in at least two ways. First, the preconditioning pulse sequence 302 acts as a series of tetanic skeletal muscle pulses 306 that induce tetany, i.e., contraction of the skeletal muscles of the patient's body, prior to receiving the higher voltage electroporation pulse sequence 304. The increase in the magnitude of the pulses 306 over time from lower to higher voltages induces or contributes to inducing tetany. This SMS prepares the patient for the higher voltage electroporation pulses 308 in the electroporation pulse sequence 304 that would otherwise shock the patient or be a painful experience for the patient. Second, the preconditioning pulse sequence 302 acts as a series of electrolysis-inducing pulses 306 that induce electrolysis near the target tissue. This creates a cytotoxic environment near the target tissue, allowing smaller electroporation pulses to be used to permeabilize the target tissue and induce cell death, and allowing larger lesions to be created with smaller electroporation pulses.

[0073] This synergistic electrolysis is caused by the application of a relatively long low voltage pulse, such as the preconditioning pulse sequence 302, to the target area. In particular, the exponentially decaying waveform 310 (or drooping waveform) behind pulse 306 of the preconditioning pulse sequence 302 causes electrolysis near the electrode. To further explain, synergistic electrolysis occurs when new chemical species are generated at the electrode interface as a result of electron transfer between the electrode and ions in the solution. The new chemical species diffuse from the electrode into the tissue in a process driven by the electrochemical potential. In physiological solutions, the electrolytic reaction changes the pH, creating an acidic region near the anode and a basic region near the cathode. The cytotoxic environment created due to the local change in pH, and the presence of several new chemical species formed during the electrolysis of the solution, in combination with electroporation permeabilization, causes cell death.

[0074] In an exemplary embodiment, the preconditioning pulse sequence 302 is delivered as a series of monopolar electrical pulses 306. A surface patch electrode 115 attached to the chest of the patient 20 receives the electrical pulses from the electroporation generator 130 and sources the electrical energy, with the surface patch electrode 115 acting as a source electrode for the electrical pulses. One or more electrodes on the electroporation catheter 105 sink the electrical energy sourced by the surface patch electrode 115, with the one or more electrodes on the electroporation catheter 105 acting as a sink for the electrical pulses. This causes the patient's skeletal muscles to contract to reach tetany, generating synergistic electrolysis near the target tissue where the electrodes of the electroporation catheter 105 are located near the target tissue.

[0075] In other embodiments, one or more electrodes on the electroporation catheter 105 receive the pulse 306 from the electroporation generator 130 and source the electrical energy, such that one or more electrodes on the electroporation catheter 105 act as source electrodes for the electrical pulse 306. A surface patch electrode 115 attached to the chest of the patient 20 sinks the electrical energy sourced by the one or more electrodes on the electroporation catheter 105, such that the surface patch electrode 115 acts as a sink for the electrical pulse.

[0076] After delivering at least some of the preconditioning pulse sequences 302, the electroporation system 60 is configured to deliver an electroporation pulse sequence 304, i.e., electroporation ablation energy, to ablate the target tissue. The electroporation pulse sequence 304 includes a short duration, high energy electroporation pulse 308. As shown, the electroporation pulse 308 of the electroporation pulse sequence 304 is biphasic, including both positive and negative pulses, for example. In an embodiment, the electroporation pulse 308 may be positive 1000 volts and negative 1000 volts. In other embodiments, the electroporation pulse 308 may be monophasic, including, for example, all positive pulses or all negative pulses.

[0077] When at least some of the pulses 206 of the preconditioning pulse sequence 302 are applied prior to application of the electroporation pulse 308, electrolysis near or at the target tissue allows for the use of an electroporation pulse 308 having a lower amplitude, for example, 250 volts per centimeter (V / cm) to 1000 V / cm, than would be typical or necessary if only an electroporation pulse were used (500 V / cm to 2,500 V / cm).

[0078] As shown, the electroporation pulse 308 of the electroporation pulse sequence 304 is delivered within the series of pulses 306 of the preconditioning pulse sequence 302. In other embodiments, the electroporation generator 130 may be configured to deliver the electroporation pulse 308 of the electroporation pulse sequence 304 after all of the pulses 306 of the preconditioning pulse sequence 302 have been delivered.

[0079] The electroporation pulses 308 of the electroporation pulse sequence 304 can be either monopolar or bipolar pulses. In an embodiment, an electrode pair (or electrode set) on the electroporation catheter 105 is selected to deliver a bipolar pulse between the selected electrode pair. Each electrode of an electrode pair may act as a source electrode and each electrode of an electrode pair may act as a sink to deliver electrical ablation energy to the target tissue.

[0080] In other embodiments, to provide a monopolar pulse, one or more electrodes on electroporation catheter 105 receive the electroporation pulse 308 of the electroporation pulse sequence 304 from electroporation generator 130 and source the electrical energy, such that one or more electrodes on electroporation catheter 105 act as source electrodes for the electrical pulse. A surface patch electrode 115 attached to the chest of patient 20 sinks the electrical energy sourced by one or more electrodes on electroporation catheter 105, such that surface patch electrode 115 acts as a sink for the electrical pulse.

[0081] In an embodiment, the electroporation system 60 includes an accelerometer 117 configured to sense contractions of the patient's skeletal muscles, such as contractions of the patient's pectoral muscles, to detect tetany. A signal from the accelerometer 117 is received by the electroporation generator 130, which processes the signal to determine whether the patient's skeletal musculature is contracting and whether tetany has been achieved. In an embodiment, the electroporation generator 130 is configured to provide the electroporation pulse sequence 304 only after tetany has been achieved in the patient. The electroporation generator 130 may provide the electroporation pulse sequence 304 during or after the preconditioning pulse sequence 302.

[0082] Thus, electroporation system 60 operates as a closed system, with surface accelerometer 117 monitoring chest vibrations and electroporation generator 130 modulating pulses 306 until tetany is achieved, after which electroporation pulse 308 is delivered. Also, in embodiments, the local impedance of the target tissue and tissue surrounding the target tissue can be measured during this time to calculate pre- and post-ablation values ​​to assess lesion efficacy.

[0083] By applying at least some of the pulses 306 in the preconditioning pulse sequence 302 prior to delivery of the electroporation pulses 308 of the electroporation pulse sequence 304, tetany or contraction of the patient's skeletal muscle can be achieved and electrolysis can establish a cytotoxic environment near or adjacent to the target tissue prior to delivery of the electroporation pulses 308 of the electroporation pulse sequence 304. This results in the ability to create the same size lesions using lower energy electroporation pulses 308 and / or fewer electroporation pulses 308 than could be created using much more energy or much more electroporation pulses 308 without the preconditioning pulse sequence 302.

[0084] 4 is a flow chart diagram illustrating a method of ablating target tissue in a patient by irreversible electroporation, according to an embodiment of the presently disclosed subject matter. Such methods and other related methods of ablating target tissue in a patient by irreversible electroporation are disclosed herein.

[0085] The method includes delivering an IRE (irreversible electroporation) pulse sequence, including delivering a preconditioning pulse sequence at 402 and delivering an electroporation pulse sequence at 404. In an embodiment, the electroporation pulse sequence is delivered during or out of the preconditioning pulse sequence. In other embodiments, the electroporation pulse sequence is delivered after the preconditioning pulse sequence has stopped. In an exemplary embodiment, the IRE pulse sequence, including the preconditioning pulse sequence and the electroporation pulse sequence, is delivered to the patient within one or more of the patient's cardiac refractory time, less than 330 milliseconds, and a time window of 100 to 250 milliseconds.

[0086] The step of delivering a preconditioning pulse sequence of 402 includes delivering a preconditioning pulse sequence between a surface patch electrode and one or more catheter electrodes on the catheter to cause electrolysis near the target tissue and tetanic skeletal muscle stimulation in the patient. In an embodiment, the preconditioning pulse sequence includes a plurality of monopolar electrical pulses sourced from the surface patch electrode and sunk by the one or more catheter electrodes. In another embodiment, the preconditioning pulse sequence includes a plurality of monopolar electrical pulses sourced from the one or more catheter electrodes and sunk by the surface patch electrode. Also, in an embodiment, the preconditioning pulse sequence includes a plurality of preconditioning pulses that are monophasic.

[0087] The preconditioning pulse sequence includes a plurality of preconditioning pulses delivered at a selected frequency and ramping from a lower voltage to a higher voltage over time. In an embodiment, the preconditioning pulse sequence includes a plurality of preconditioning pulses delivered at about 1 kilohertz. Also, in an embodiment, the preconditioning pulse sequence includes a plurality of preconditioning pulses ramped from 0 volts to a voltage of 5-100 volts. The ramping of the pulses from a lower voltage to a higher voltage over time contributes to inducing a tetanic skeletal muscle contraction in the patient. Also, the preconditioning pulse sequence includes a plurality of preconditioning pulses including an exponentially decaying trailing waveform that induces or contributes to electrolysis near the target tissue.

[0088] The step of delivering an electroporation pulse sequence of 404 includes delivering an electroporation pulse sequence to a catheter electrode on the catheter to cause irreversible electroporation ablation of the target tissue. In an embodiment, the electroporation pulse sequence includes a plurality of bipolar electrical pulses delivered to one or more catheter electrode pairs of the catheter electrodes. In other embodiments, the electroporation pulse sequence includes a plurality of monopolar electrical pulses delivered between a surface patch electrode and one or more catheter electrodes on the catheter.

[0089] In an embodiment, the method further includes monitoring an accelerometer 117 on the patient, the accelerometer configured to sense contractions of the patient's skeletal muscles to detect tetany, such as contractions of the patient's pectoral muscles. In a closed loop system, signals from the accelerometer 117 are received by the electroporation generator 130, which processes the signals to determine whether the patient's skeletal musculature is contracting and whether tetany has been achieved. In an embodiment, the electroporation generator 130 is configured to provide an electroporation pulse sequence only after tetany has been achieved in the patient, which may be during or after a preconditioning pulse sequence.

[0090] Also, in an embodiment, the method includes monitoring the local impedance of the target tissue and tissue surrounding the target tissue to calculate pre-ablation and post-ablation values ​​for assessment of lesion effectiveness.

[0091] Various modifications and additions can be made to the exemplary embodiments described without departing from the scope of the present disclosure. For example, while the above embodiments refer to certain features, the scope of the present disclosure also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present disclosure is intended to encompass all such alternatives, modifications, and variations that fall within the scope of the claims, together with all equivalents thereof.

Claims

1. 1. An electroporation ablation system for treating target tissue in a patient, comprising:

1. An ablation catheter comprising: A handle and a shaft having a distal end; a catheter electrode located at the distal end of the shaft and spatially arranged to generate an electric field in the target tissue in response to an electrical pulse; an ablation catheter comprising: an electroporation generator operatively coupled to the catheter electrodes and configured to deliver the electrical pulses to one or more catheter electrodes in irreversible electroporation pulse sequences, the irreversible electroporation pulse sequences including a preconditioning pulse sequence and an electroporation pulse sequence; The preconditioning pulse sequence includes a plurality of preconditioning electrical pulses configured to induce electrolysis near the target tissue and tetanic skeletal muscle stimulation in the patient.

2. 10. The electroporation ablation system of claim 1, comprising a surface patch electrode attached to the patient and configured to generate an electric field within the patient in response to the electrical pulse.

3. The electroporation ablation system of claim 2 , wherein the preconditioning pulse sequence comprises a plurality of monopolar electrical pulses sourced from the surface patch electrode and sunk by the one or more catheter electrodes.

4. The electroporation ablation system of claim 2 , wherein the preconditioning pulse sequence comprises a plurality of monopolar electrical pulses sourced from the one or more catheter electrodes and sunk by the surface patch electrode.

5. 5. The electroporation ablation system of claim 1, wherein the preconditioning pulse sequence comprises a plurality of bipolar electrical pulses sourced from at least one of the one or more catheter electrodes and sunk by at least another one of the one or more catheter electrodes.

6. The electroporation ablation system of any one of claims 1 to 5, wherein the preconditioning pulse sequence comprises a plurality of preconditioning pulses delivered at selected frequencies.

7. The electroporation ablation system of any one of claims 1 to 6, wherein the preconditioning pulse sequence comprises a plurality of preconditioning pulses that are ramped from a lower voltage to a higher voltage over time.

8. 8. The electroporation ablation system of claim 1, wherein the preconditioning pulse sequence includes a plurality of preconditioning pulses including an exponentially decaying trailing waveform that induces electrolysis near the target tissue.

9. The electroporation ablation system of any one of claims 1 to 8, wherein the preconditioning pulse sequence comprises multiple preconditioning pulses that are monophasic.

10. 10. The electroporation ablation system of any one of claims 1-9, wherein the irreversible electroporation pulse sequence, including the preconditioning pulse sequence and the electroporation pulse sequence, is delivered to the patient within one or more of a time window of the patient's cardiac refractory time, less than 330 milliseconds, and between 100 and 250 milliseconds.

11. The electroporation ablation system of any one of claims 1 to 10, wherein the electroporation pulse sequence is delivered within the preconditioning pulse sequence.

12. The electroporation ablation system of any one of claims 1 to 11, wherein the electroporation pulse sequence comprises a plurality of bipolar electrical pulses delivered to one or more catheter electrode pairs of the catheter electrodes.

13. 13. The electroporation ablation system of any one of claims 1 to 12, comprising an accelerometer configured to monitor skeletal muscle stimulation of the patient, wherein the electroporation ablation system is a closed loop system such that the electroporation generator is configured to deliver the preconditioning pulse sequence, detect tetany in the patient, and thereafter deliver the electroporation pulse sequence, and local impedance is measured to calculate pre-ablation and post-ablation values ​​and assess lesion efficacy.

14. 1. An electroporation ablation system for treating target tissue in a patient, comprising:

1. An ablation catheter comprising: A handle and a shaft having a distal end; a catheter electrode located at the distal end of the shaft and spatially arranged to generate an electric field in the target tissue in response to an electrical pulse; an ablation catheter comprising: an electroporation generator operatively coupled to a plurality of electrodes, the plurality of electrodes comprising one or more of a surface patch electrode and one or more catheter electrodes, the electroporation generator configured to deliver the electrical pulses to the plurality of electrodes in an irreversible electroporation pulse sequence comprising a preconditioning pulse sequence and an electroporation pulse sequence, the electroporation generator delivering the electroporation pulse sequence during the preconditioning pulse sequence; The preconditioning pulse sequence includes a plurality of electrical pulses configured to induce electrolysis near the target tissue and tetanic skeletal muscle stimulation in the patient.

Citation Information

Patent Citations

  • Pulse generator for irreversible electroporation

    CN111227926A

  • Systems, devices, and methods for delivering pulsed electric field ablation energy to endocardial tissue

    JP2019503773A

  • Unwanted stimulation detection during cardiac pacing

    US20150066102A1

  • Electroporation system and method of preconditioning tissue for electroporation therapy

    US20180289417A1

  • Methods, systems, and apparatuses for tissue ablation using a modulated exponential decay pulse

    WO2020051241A1